Artisan Partners’s Rapport Therapeutics RAPP Stock Holding History

Artisan Partners’s Portfolio RAPP Stock Details RAPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$14.7M	Buy	+437,608	New	+$18.9M	0.03%	219

Other funds holding RAPP

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Artisan Partners's RAPP Position: Q3 2026 in Review

Artisan Partners opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 437,608 shares worth $14.7M. The stake represents 0.03% of the portfolio and ranks #219 among its holdings.

104 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

Artisan Partners held 437,608 shares of Rapport Therapeutics worth $14.7M as of Q3 2026.
Rapport Therapeutics was a new Artisan Partners position in Q3 2026.
Rapport Therapeutics made up 0.03% of Artisan Partners's portfolio in Q3 2026, its #219 holding.
104 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Artisan Partners's 13F filing for Q3 2026, filed 13 Nov 2026.